OneTest Premium Cancer Blood Test

$499.00

OneTest™ Premium is an AI-powered, multi-cancer early detection blood test that evaluates an individual's risk for up to eight of the most common cancers by analyzing 11 to 12 specific biological markers.

This test is intended to be used as a complement to, not a replacement for, routine cancer screenings.

OneTest™ Premium is an AI-powered, multi-cancer early detection blood test that evaluates an individual's risk for up to eight of the most common cancers by analyzing 11 to 12 specific biological markers.

This test is intended to be used as a complement to, not a replacement for, routine cancer screenings.

Product
Antigen-based MCED that provides a predictive risk assessment of developing cancer within 12 months. Based on machine-learning tumor biomarker analysis of real-world cancer studies.

Early Detection
OneTest is designed to aid in the detection of early stage cancers, and in research studies has been shown to detect the risk of future cancer using tumor antigen testing and analysis.

OneTest Provides:
Unique Tumor Biomarker Analysis
PSA | AFP | CEA | CA19-9 | CYFRA 21-1 | CA 125 | CA15-3
Liver, Prostate, Cervical, Ovarian, Breast, Lung, Colorectal, Pancreatic...
Likelihood of Having Cancer
Provides a 12-month window into an individuals risk of having or developing cancer using our patented software algorithm.

Validated by Real World Data
The only MCED to be validated by real-world data studies.

Rapid Reporting Process
Results available within 7-10 days of sample delivery

Aggregated Biomarker Values
Cross-references biomarkers associated with 29 cancers.